• The team designed a drug called MP-MUS that destroyed 90 to 95 percent of malignant glioma cells, yet in other experiments did not seem to adversely affect healthy human brain cells (in vitro).
  • This compliments a soon to be published extensive study showing the same drug can treat human brain cancer grown in the brains of mice.
  • Researchers hope to begin testing the drug in human clinical trials in 2016 or 2017.

Share This Article